EXEMESTANE INOVAMED
Land: Israel
Sprog: engelsk
Kilde: Ministry of Health
Nogle dokumenter til dette produkt er ikke tilgængelige i øjeblikket, du kan sende en anmodning til vores kundeservice, og vi vil underrette dig, så snart vi er i stand til at få dem.
Send anmodning.
Send anmodning.
Aktiv bestanddel:
EXEMESTANE 25 MG
Tilgængelig fra:
INOVAMED LTD
ATC-kode:
L02BG06
Lægemiddelform:
FILM COATED TABLETS
Indgivelsesvej:
PER OS
Fremstillet af:
SYNTHON B.V., NETHERLANDS
Terapeutisk gruppe:
EXEMESTANE
Terapeutiske indikationer:
Exemestane Inovamed is indicated for the treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. Exemestane Inovamed is also indicated for the treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies. Exemestane Inovamed is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.
Autorisation dato:
2013-11-01
